James A Geraghty's Net Worth
$2.77 Million
Who is James A Geraghty?
James A Geraghty has an estimated net worth of $2.77 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, Fulcrum Therapeutics, Inc., PIERIS PHARMACEUTICALS, INC., Voyager Therapeutics, Inc., IDERA PHARMACEUTICALS, INC., Orchard Therapeutics plc, JUNIPER PHARMACEUTICALS INC, and GTC BIOTHERAPEUTICS INC.
SEC CIK
James A Geraghty's CIK is 0001239746
Past Insider Trading and Trends
2016 was James A Geraghty's most active year for acquiring shares with 10 total transactions. James A Geraghty's most active month to acquire stocks was the month of May. 2011 was James A Geraghty's most active year for disposing of shares, totalling 14 transactions. James A Geraghty's most active month to dispose stocks was the month of March. 2009 saw James A Geraghty paying a total of $1,210,425.70 for 70,791 shares, this is the most they've acquired in one year. In 2009 James A Geraghty cashed out on 73,750 shares for a total of $1,920,081.25, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENZYME CORP No price found
Senior Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.96K |
$74.00 | -$1,088,318.00 |
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| -18.67% | -1.00K |
$48.81 | -$48,810.00 | 4.36K |
Jun 11
| |||
Form 4
| +99.48% | 2.67K |
$45.59 | -$106,179.11 | 5.36K |
May 24 - May 25
| |||
Form 4
|
—
|
0
|
$42.30 | -$720,906.25 | 2.35K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
| +12.39% | 10K |
$9.16 | $91,600.00 | 90.71K |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PIERIS PHARMACEUTICALS, INC. (PIRS) Snapshot price: $15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1 |
$1.00 | $1.00 | 1 |
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
| +100.00% | 10K |
$5.75 | $57,500.00 | 20K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
|
∞
| 10K |
$4.82 | $48,200.00 | 10K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +4.08% | 3K |
$19.39 | $58,170.00 | 76.59K |
Sep 10
| |||
Form 4
| +4.25% | 3K |
$18.31 | $54,930.00 | 73.59K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IDERA PHARMACEUTICALS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +2.28% | 9.72K |
$1.63 | $15,843.60 | 435.37K |
Jul 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| +2.41% | 10K |
$1.34 | $13,400.00 | 425.65K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| +0.73% | 3K |
$3.52 | $10,560.00 | 415.65K |
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +2.48% | 10K |
$2.65 | $26,500.00 | 412.65K |
May 27
| |||
Form 4
| +0.41% | 1.64K |
$4.41 | $7,214.76 | 402.65K |
Apr 1
| |||
Form 4
| +0.25% | 1.01K |
$4.75 | $4,811.75 | 401.01K |
Jan 2
| |||
Form 4
| +11.11% | 40K |
$2.72 | $108,800.00 | 400K |
Dec 6
| |||
Form 4
| +20.00% | 60K |
$1.90 | $114,000.00 | 360K |
Sep 16
| |||
Form 4
|
∞
| 300K |
$1.75 | $525,000.00 | 300K |
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||